The Biospecimens Core in the University of Iowa/Mayo Clinic Lymphoma SPORE provides a coordinated, centralized and dedicated core for the procurement, processing and annotation of biospecimens from patients with lymphoma, chronic lymphocytic leukemia and small lymphocytic lymphoma.
The goal of the Biospecimens Core is to procure a variety of specimens from all patients involved in Lymphoma SPORE protocols and all patients newly diagnosed with lymphoma who are seen at the University of Iowa or Mayo Clinic in Rochester, Minnesota, who are enrolled in certain SPORE studies.
Specifically, the Biospecimens Core:
- Provides accurate classification of all lymphomas from patients enrolled in Lymphoma SPORE protocols.
- Collects, processes, banks and distributes biologic specimens from University of Iowa and Mayo Clinic patients for translational research.
- Tracks all biospecimens and ensures linkage to clinical and outcomes data and other related data.
- Serves as a resource of expertise, collaborative support and service for projects. Services include pathology review and classification, specimen review, immunohistochemistry, flow cytometry, in situ hybridization, fluorescence in situ hybridization, cytogenetics, laser capture microdissection, tissue arrays, gene expression profiling analyses, and digital image analysis.
The director of the Biospecimens Core is:
The co-director is:
- Sergei Syrbu, M.D., Ph.D., of the University of Iowa